AKAN
Akanda Corp
NASDAQ: AKAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$24.79
-4.64% today
Updated 2026-06-05
Market cap
$9.04M
P/E ratio
0.02
P/S ratio
10.80x
EPS (TTM)
$696.80
Dividend yield
—
52W range
$2 – $121
Volume
2.8M
Akanda Corp (AKAN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$24.79
12-Month target
$1.55
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.02x (capped 25x) · Margin: -266.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.